• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.12% Nasdaq Up0.71%

    Evoke Pharma, Inc. (EVOK)

    -NasdaqCM
    6.56 0.00(0.00%) Apr 24, 2:32PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue -   -   -  
    Cost of Revenue -   -   -  
    Gross Profit -   -   -  
    Operating Expenses
    Research Development9,992  957  1,166  
    Selling General and Administrative3,158  1,645  837  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (13,150) (2,602) (2,002)
    Income from Continuing Operations
    Total Other Income/Expenses Net10  (75)9  
    Earnings Before Interest And Taxes(13,140)(2,677)(1,993)
    Interest Expense108  160  24  
    Income Before Tax(13,248)(2,836)(2,018)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(13,248)(2,836)(2,018)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (13,248) (2,836) (2,018)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (13,248) (2,836) (2,018)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.